198 related articles for article (PubMed ID: 18221758)
1. fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease.
Saft C; Schüttke A; Beste C; Andrich J; Heindel W; Pfleiderer B
Neuropsychologia; 2008 Apr; 46(5):1279-89. PubMed ID: 18221758
[TBL] [Abstract][Full Text] [Related]
2. Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease.
Hennenlotter A; Schroeder U; Erhard P; Haslinger B; Stahl R; Weindl A; von Einsiedel HG; Lange KW; Ceballos-Baumann AO
Brain; 2004 Jun; 127(Pt 6):1446-53. PubMed ID: 15090475
[TBL] [Abstract][Full Text] [Related]
3. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G; Tishler TA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
[TBL] [Abstract][Full Text] [Related]
4. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.
Wolf RC; Vasic N; Schönfeldt-Lecuona C; Landwehrmeyer GB; Ecker D
Brain; 2007 Nov; 130(Pt 11):2845-57. PubMed ID: 17855375
[TBL] [Abstract][Full Text] [Related]
5. Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study.
Enzi B; Edel MA; Lissek S; Peters S; Hoffmann R; Nicolas V; Tegenthoff M; Juckel G; Saft C
Exp Neurol; 2012 May; 235(1):256-64. PubMed ID: 22366326
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted imaging in Huntington's disease.
Seppi K; Schocke MF; Mair KJ; Esterhammer R; Weirich-Schwaiger H; Utermann B; Egger K; Brenneis C; Granata R; Boesch S; Poewe W; Wenning GK
Mov Disord; 2006 Jul; 21(7):1043-7. PubMed ID: 16570300
[TBL] [Abstract][Full Text] [Related]
7. Functional MRI study of a serial reaction time task in Huntington's disease.
Kim JS; Reading SA; Brashers-Krug T; Calhoun VD; Ross CA; Pearlson GD
Psychiatry Res; 2004 May; 131(1):23-30. PubMed ID: 15246452
[TBL] [Abstract][Full Text] [Related]
8. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
[TBL] [Abstract][Full Text] [Related]
9. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
10. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
Kassubek J; Juengling FD; Ecker D; Landwehrmeyer GB
Cereb Cortex; 2005 Jun; 15(6):846-53. PubMed ID: 15459079
[TBL] [Abstract][Full Text] [Related]
11. Reduced fMRI activation of an occipital area in recently detoxified alcohol-dependent patients in a visual and acoustic stimulation paradigm.
Hermann D; Smolka MN; Klein S; Heinz A; Mann K; Braus DF
Addict Biol; 2007 Mar; 12(1):117-21. PubMed ID: 17407505
[TBL] [Abstract][Full Text] [Related]
12. Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease.
Finke K; Bublak P; Dose M; Müller HJ; Schneider WX
Brain; 2006 May; 129(Pt 5):1137-51. PubMed ID: 16504973
[TBL] [Abstract][Full Text] [Related]
13. The role of the striatum in rule application: the model of Huntington's disease at early stage.
Teichmann M; Dupoux E; Kouider S; Brugières P; Boissé MF; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
Brain; 2005 May; 128(Pt 5):1155-67. PubMed ID: 15788544
[TBL] [Abstract][Full Text] [Related]
14. Stimulus-response compatibility in Huntington's disease: a cognitive-neurophysiological analysis.
Beste C; Saft C; Andrich J; Gold R; Falkenstein M
J Neurophysiol; 2008 Mar; 99(3):1213-23. PubMed ID: 18184888
[TBL] [Abstract][Full Text] [Related]
15. Task-set switching deficits in early-stage Huntington's disease: implications for basal ganglia function.
Aron AR; Watkins L; Sahakian BJ; Monsell S; Barker RA; Robbins TW
J Cogn Neurosci; 2003 Jul; 15(5):629-42. PubMed ID: 12965037
[TBL] [Abstract][Full Text] [Related]
16. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P
Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847
[TBL] [Abstract][Full Text] [Related]
17. Functional compensation or pathology in cortico-subcortical interactions in preclinical Huntington's disease?
Beste C; Saft C; Yordanova J; Andrich J; Gold R; Falkenstein M; Kolev V
Neuropsychologia; 2007 Oct; 45(13):2922-30. PubMed ID: 17692347
[TBL] [Abstract][Full Text] [Related]
18. Brain structure in preclinical Huntington's disease.
Paulsen JS; Magnotta VA; Mikos AE; Paulson HL; Penziner E; Andreasen NC; Nopoulos PC
Biol Psychiatry; 2006 Jan; 59(1):57-63. PubMed ID: 16112655
[TBL] [Abstract][Full Text] [Related]
19. Abnormal microstructures of the basal ganglia in schizophrenia revealed by diffusion tensor imaging.
Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Noguchi H; Nakabayashi T; Hori H; Harada S; Kunugi H; Saitoh O; Ohnishi T
World J Biol Psychiatry; 2009; 10(1):65-9. PubMed ID: 19253093
[TBL] [Abstract][Full Text] [Related]
20. Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study.
Gray MA; Egan GF; Ando A; Churchyard A; Chua P; Stout JC; Georgiou-Karistianis N
Exp Neurol; 2013 Jan; 239():218-28. PubMed ID: 23123406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
